RealMoney

Latest from Helene Meisler

Real Money authors - Helene Meisler

Is This Market Really So Miserable?

Helene Meisler May 25, 2022 6:00 AM EDT

Let's look at these two weeks of pain and see if it's as awful as we think it is.

Markets

Buying Momentum SNAPs Under Weight of Recession Worries

James "Rev Shark" DePorre
May 24, 2022 4:26 PM EDT

The Dow held its own, but under the surface it wasn't so pretty as the correction churns on.
Investing

Boston Scientific Could Be Wicked Good in This Kind of Market

Brad Ginesin
May 24, 2022 2:13 PM EDT

It's Easy to Overlook This Basic Rule of Investing

Paul Price

May 24, 2022 7:00 AM EDT
Stocks

Let's Pop the Hood on AutoZone to See How Its Engine Is Running

Stephen Guilfoyle
May 24, 2022 10:20 AM EDT

AT&T Should Dial It Up

Ed Ponsi

May 24, 2022 10:31 AM EDT
ETFs

Can This China Tech ETF Surprise on the Upside?

Bruce Kamich
May 24, 2022 1:18 PM EDT

Sometimes the most uncomfortable trade can be the best trade.

UPGRADES & DOWNGRADES

TWOU

2U Cut to Underweight at Piper Sandler

May 25, 2022

05:45 AM EDT

2U (TWOU) was cut to Underweight at Piper Sandler, with a price target of $9.
AMLX

Amylyx Pharmaceuticals Rated New Buy at Citi

May 25, 2022

05:43 AM EDT

Amylyx Pharmaceuticals (AMLX) was rated a New Buy at Citi, with a price target of $21.
MMP

Magellan Midstream Raised to Overweight at JPMorgan

May 25, 2022

05:42 AM EDT

Magellan Midstream (MMP) was raised to Overweight at JPMorgan, with a price target of $57.
CME

CME Group Raised to Outperform at Oppenheimer

May 25, 2022

05:41 AM EDT

CME Group (CME) was raised to Outperform at Oppenheimer, with a price target of $223.
ZG

Zillow Rated New Underperform at Bernstein

May 24, 2022

05:47 AM EDT

Zillow (ZG) was rated New Underperform at Bernstein.
See More

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login